Avinger, Inc. (AVGR)

Market Cap	1.52M
Revenue (ttm)	7.26M -6.3%
Net Income	-17.35M
EPS	-6.23
Shares Out	3.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,592,021
Open	0.5560
Previous Close	0.5980
Day's Range	0.4630 - 0.6060
52-Week Range	0.3630 - 4.9200
Beta	1.10
Analysts	Strong Buy
Price Target	5.00 (+954.85%)
Earnings Date	Mar 19, 2025

About AVGR

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the O...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jan 30, 2015
• Employees: 72
• Stock Exchange: NASDAQ
• Ticker Symbol: AVGR
• Website: https://avinger.com

Financial Performance

In 2023, Avinger's revenue was $7.65 million, a decrease of -7.51% compared to the previous year's $8.27 million. Losses were -$18.32 million, -32.76% less than in 2022.

Analyst Summary

According to one analyst, the rating for AVGR stock is "Strong Buy" and the 12-month stock price target is $5.0.

Price Target

$5.0

(954.85% upside)

Analyst Consensus: Strong Buy